These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1795631)

  • 1. Monoclonal antibodies directed against the envelope glycoproteins of La Crosse virus.
    Ludwig GV; Israel BA; Christensen BM; Yuill TM; Schultz KT
    Microb Pathog; 1991 Dec; 11(6):411-21. PubMed ID: 1795631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two monoclonal antibodies against La Crosse virus show host-dependent neutralizing activity.
    Grady LJ; Kinch W
    J Gen Virol; 1985 Dec; 66 ( Pt 12)():2773-6. PubMed ID: 4067586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological activities of monoclonal antibodies reactive with antigenic sites mapped on the G1 glycoprotein of La Crosse virus.
    Kingsford L; Ishizawa LD; Hill DW
    Virology; 1983 Sep; 129(2):443-55. PubMed ID: 6194614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and localization of conserved antigenic epitopes on the G2 proteins of California serogroup Bunyaviruses.
    Cheng LL; Schultz KT; Yuill TM; Israel BA
    Viral Immunol; 2000; 13(2):201-13. PubMed ID: 10893000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA-based vaccine against La Crosse virus: protective immune response mediated by neutralizing antibodies and CD4+ T cells.
    Schuh T; Schultz J; Moelling K; Pavlovic J
    Hum Gene Ther; 1999 Jul; 10(10):1649-58. PubMed ID: 10428210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of proteolytic cleavage of La Crosse virus G1 glycoprotein on antibody neutralization.
    Kingsford L; Hill DW
    J Gen Virol; 1983 Oct; 64 (Pt 10)():2147-56. PubMed ID: 6352863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibodies against La Crosse virus.
    Grady LJ; Srihongse S; Grayson MA; Deibel R
    J Gen Virol; 1983 Aug; 64 (Pt 8)():1699-704. PubMed ID: 6192204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection from La Crosse virus encephalitis with recombinant glycoproteins: role of neutralizing anti-G1 antibodies.
    Pekosz A; Griot C; Stillmock K; Nathanson N; Gonzalez-Scarano F
    J Virol; 1995 Jun; 69(6):3475-81. PubMed ID: 7745694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of La Crosse virus glycoproteins in attachment of virus to host cells.
    Ludwig GV; Israel BA; Christensen BM; Yuill TM; Schultz KT
    Virology; 1991 Apr; 181(2):564-71. PubMed ID: 1673039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epitope mapping studies with neutralizing and non-neutralizing monoclonal antibodies to the G1 and G2 envelope glycoproteins of Hantaan virus.
    Wang M; Pennock DG; Spik KW; Schmaljohn CS
    Virology; 1993 Dec; 197(2):757-66. PubMed ID: 7504368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A G1 glycoprotein epitope of La Crosse virus: a determinant of infection of Aedes triseriatus.
    Sundin DR; Beaty BJ; Nathanson N; Gonzalez-Scarano F
    Science; 1987 Jan; 235(4788):591-3. PubMed ID: 3810159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for three separate antigenic sites on the G1 protein of La Crosse Virus.
    Grady LJ; Sanders ML; Campbell WP
    Virology; 1983 Apr; 126(1):395-7. PubMed ID: 6189289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzyme processing of La Crosse virus glycoprotein G1: a bunyavirus-vector infection model.
    Ludwig GV; Christensen BM; Yuill TM; Schultz KT
    Virology; 1989 Jul; 171(1):108-13. PubMed ID: 2662577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A recombinant chimeric La Crosse virus expressing the surface glycoproteins of Jamestown Canyon virus is immunogenic and protective against challenge with either parental virus in mice or monkeys.
    Bennett RS; Gresko AK; Nelson JT; Murphy BR; Whitehead SS
    J Virol; 2012 Jan; 86(1):420-6. PubMed ID: 22013033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epitopes of the G1 glycoprotein of La Crosse virus form overlapping clusters within a single antigenic site.
    Najjar JA; Gentsch JR; Nathanson N; Gonzalez-Scarano F
    Virology; 1985 Jul; 144(2):426-32. PubMed ID: 2414920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced neutralization of La Crosse virus by the binding of specific pairs of monoclonal antibodies to the G1 glycoprotein.
    Kingsford L
    Virology; 1984 Jul; 136(2):265-73. PubMed ID: 6205500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutralizing monoclonal antibodies directed to infectious bovine rhinotracheitis virus.
    Chang LW; Zee YC; Pritchett RF; Ardans AA
    Arch Virol; 1986; 88(3-4):203-15. PubMed ID: 3010905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of specific monoclonal antibodies on La Crosse virus neutralization: aggregation, inactivation by Fab fragments, and inhibition of attachment to baby hamster kidney cells.
    Kingsford L; Boucquey KH; Cardoso TP
    Virology; 1991 Feb; 180(2):591-601. PubMed ID: 1703370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibodies specific for the G1 glycoprotein of La Crosse virus that react with other California serogroup viruses.
    Kingsford L; Boucquey KH
    J Gen Virol; 1990 Mar; 71 ( Pt 3)():523-30. PubMed ID: 2179465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigenic analysis of Punta Toro virus and identification of protective determinants with monoclonal antibodies.
    Pifat DY; Osterling MC; Smith JF
    Virology; 1988 Dec; 167(2):442-50. PubMed ID: 2462308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.